Cargando…
Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4(+) T cells through regulating type 2 conventional dendritic cells
Rationale: An immunosuppressive tumor microenvironment (TME) is a major obstacle in tumor immunotherapy. Stimulator of interferon genes (STING) agonists trigger an inflammatory innate immune response to potentially overcome tumor immunosuppression. While STING agonists may hold promise as potential...
Autores principales: | Luo, Jing, Pang, Shuju, Hui, Zhenzhen, Zhao, Hua, Xu, Shilei, Yu, Wenwen, Yang, Lili, Sun, Qian, Hao, Xishan, Wei, Feng, Wang, Jian, Ren, Xiubao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526657/ https://www.ncbi.nlm.nih.gov/pubmed/37771774 http://dx.doi.org/10.7150/thno.86792 |
Ejemplares similares
-
Liposomal Delivery of MIW815 (ADU-S100) for Potentiated STING Activation
por: Ji, Nan, et al.
Publicado: (2023) -
Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potential Immunotherapy for Prostate Cancer
por: Esteves, Ana M., et al.
Publicado: (2021) -
Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model
por: Zaidi, Ali H., et al.
Publicado: (2021) -
Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models
por: Papaevangelou, Efthymia, et al.
Publicado: (2023) -
The influence of accessory dwelling unit (ADU) policy on the contributing factors to ADU development: an assessment of the city of Los Angeles
por: Kim, Dohyung, et al.
Publicado: (2023)